Maternal death: lessons for anaesthesia and critical care. [PDF]
Walls A, Plaat F, Delgado AM.
europepmc +1 more source
Genetic epilepsies with myoclonic seizures: Mechanisms and syndromes
Abstract Genetic epilepsy with myoclonic seizures encompasses a heterogeneous spectrum of conditions, ranging from benign and self‐limiting forms to severe, progressive disorders. While their causes are diverse, a significant proportion stems from genetic abnormalities.
Antonietta Coppola +3 more
wiley +1 more source
Traditional Versus Contemporary Models for Identifying Causes of Maternal Death: A Population-Based Study. [PDF]
Sabr Y +4 more
europepmc +1 more source
Strategies to Reduce Maternal Death Rate and Improve the Provision of Quality Healthcare Services in Selected Hospitals of Vhembe District Limpopo Province. [PDF]
Mahada T, Tshitangano TG, Mudau AG.
europepmc +1 more source
MATERNAL DEATH IN MITI-MURHESA HEALTH ZONE, SOUTH KIVU, DRC
Blaise Irenge Masirika, Balume Mulanga
openalex +1 more source
Precision therapies for genetic epilepsies in 2025: Promises and pitfalls
Abstract By targeting the underlying etiology, precision therapies offer an exciting paradigm shift to improve the stagnant outcomes of drug‐resistant epilepsies, including developmental and epileptic encephalopathies. Unlike conventional antiseizure medications (ASMs) which only treat the symptoms (seizures) but have no effect on the underlying ...
Shuyu Wang +3 more
wiley +1 more source
Maternal death at 28 weeks gestation due to vascular rupture of placenta accreta. [PDF]
Magdoud K +7 more
europepmc +1 more source
Target areas to reduce the burden of maternal death due to obstetric hemorrhage in Ethiopia. [PDF]
Tesfay N +4 more
europepmc +1 more source
The multiple hit model of infantile and epileptic spasms: The 2025 update
Abstract Objective Infantile and epileptic spasms syndrome (IESS) is a developmental and epileptic encephalopathy manifesting with epileptic spasms and poor neurodevelopmental outcomes. There is an urgent need for the development of more effective and tolerated therapies.
Aristea S. Galanopoulou +6 more
wiley +1 more source

